Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.

Transl Neurodegener · 2023 · PMC10694940 · PMID 38049923

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The PDDC-treated PS19 mice showed a trend of reduced weight loss; however, the reduction was not significantly different from the vehicle-treated PS19 mice (Fig. 2 c).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.